Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.
作者信息
Connolly K J, Hammer S M
机构信息
Department of Medicine, New England Deaconess Hospital, Boston, Massachusetts.
出版信息
Antimicrob Agents Chemother. 1992 Mar;36(3):509-20. doi: 10.1128/AAC.36.3.509.
Abstract
摘要
相似文献
1
Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.抗逆转录病毒疗法：超越单药逆转录酶抑制的策略。
Antimicrob Agents Chemother. 1992 Mar;36(3):509-20. doi: 10.1128/AAC.36.3.509.
2
HIV regulatory proteins: potential targets for therapeutic intervention.HIV调节蛋白：治疗干预的潜在靶点。
AIDS Res Hum Retroviruses. 1992 Feb;8(2):175-81. doi: 10.1089/aid.1992.8.175.
3
HIV-1 regulatory proteins: targets for novel drug development.HIV-1调节蛋白：新型药物研发的靶点
Expert Opin Investig Drugs. 2002 Aug;11(8):1099-115. doi: 10.1517/13543784.11.8.1099.
4
Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA molecule.联合基因疗法：单个RNA分子对人类免疫缺陷病毒Tat和Rev功能的协同抑制作用
Hum Gene Ther. 2000 Apr 10;11(6):807-15. doi: 10.1089/10430340050015428.
5
Combinative interactions of a human immunodeficiency virus (HIV) Tat antagonist with HIV reverse transcriptase inhibitors and an HIV protease inhibitor.一种人类免疫缺陷病毒（HIV）反式激活因子拮抗剂与HIV逆转录酶抑制剂及HIV蛋白酶抑制剂的联合相互作用。
Antimicrob Agents Chemother. 1994 Feb;38(2):348-52. doi: 10.1128/AAC.38.2.348.
6
Merged screening for human immunodeficiency virus Tat and Rev inhibitors.人类免疫缺陷病毒Tat和Rev抑制剂的联合筛选
J Biomol Screen. 2001 Jun;6(3):179-87. doi: 10.1177/108705710100600308.
7
New developments in antiretroviral drug therapy for HIV infection.用于治疗HIV感染的抗逆转录病毒药物疗法的新进展。
AIDS Clin Rev. 1992:69-104.
8
A new contained human immunodeficiency virus type 1 host cell system for evaluation of antiviral activities of interferons and other agents in vitro.一种用于体外评估干扰素及其他药物抗病毒活性的新型携带1型人类免疫缺陷病毒的宿主细胞系统。
Antiviral Res. 1999 Jul;42(3):177-87. doi: 10.1016/s0166-3542(99)00014-5.
9
Present status and future prospects for HIV therapies.HIV治疗的现状与未来前景。
Science. 1993 May 28;260(5112):1286-93. doi: 10.1126/science.7684163.
10
RNAi in combination with a ribozyme and TAR decoy for treatment of HIV infection in hematopoietic cell gene therapy.RNA干扰联合核酶和TAR诱饵在造血细胞基因治疗中用于治疗HIV感染
Ann N Y Acad Sci. 2006 Oct;1082:172-9. doi: 10.1196/annals.1348.006.
引用本文的文献
1
Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin.金丝桃素和假金丝桃素的单剂量及稳态药代动力学
Antimicrob Agents Chemother. 1996 Sep;40(9):2087-93. doi: 10.1128/AAC.40.9.2087.
2
Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells.能阻止1型人类免疫缺陷病毒进入细胞的三萜衍生物。
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3564-8. doi: 10.1073/pnas.91.9.3564.
3
Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.异羟肟酸酯化合物与2',3'-双脱氧肌苷在感染的静息人淋巴细胞中对1型人类免疫缺陷病毒的协同作用
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11017-21. doi: 10.1073/pnas.91.23.11017.
4
Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).人类免疫缺陷病毒感染中的抗病毒治疗。现状（第二部分）
Drugs. 1993 May;45(5):637-53. doi: 10.2165/00003495-199345050-00002.
本文引用的文献
1
Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma.重组白细胞A干扰素对患卡波西肉瘤同性恋男性疗效的初步观察
N Engl J Med. 1983 May 5;308(18):1071-6. doi: 10.1056/NEJM198305053081806.
2
Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome.重组α-2干扰素治疗与获得性免疫缺陷综合征相关的卡波西肉瘤。
Ann Intern Med. 1984 May;100(5):671-6. doi: 10.7326/0003-4819-100-5-671.
3
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.CD4（T4）抗原是艾滋病逆转录病毒受体的重要组成部分。
Nature. 1984;312(5996):763-7. doi: 10.1038/312763a0.
4
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.T淋巴细胞T4分子作为人类逆转录病毒LAV的受体。
Nature. 1984;312(5996):767-8. doi: 10.1038/312767a0.
5
Prospects for the control of AIDS by immunizing seropositive individuals.通过对血清反应阳性个体进行免疫来控制艾滋病的前景。
Nature. 1987;327(6122):473-6. doi: 10.1038/327473a0.
6
Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.可溶性分泌形式的CD4抗原对HIV-1感染性的阻断作用。
Science. 1987 Dec 18;238(4834):1704-7. doi: 10.1126/science.3500514.
7
Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.寡脱氧核苷酸的硫代磷酸酯类似物：人类免疫缺陷病毒复制及细胞病变效应的抑制剂
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7706-10. doi: 10.1073/pnas.84.21.7706.
8
The sor gene of HIV-1 is required for efficient virus transmission in vitro.HIV-1的sor基因是体外有效病毒传播所必需的。
Science. 1987 Aug 21;237(4817):888-93. doi: 10.1126/science.3497453.
9
HIV-specific cytotoxic T lymphocytes in seropositive individuals.血清反应阳性个体中的HIV特异性细胞毒性T淋巴细胞。
Nature. 1987;328(6128):345-8. doi: 10.1038/328345a0.
10
Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.叠氮胸苷与重组αA干扰素在体外对人类免疫缺陷病毒的协同抑制作用。
Antimicrob Agents Chemother. 1987 Feb;31(2):168-72. doi: 10.1128/AAC.31.2.168.
Zotero 插件